Vicore Pharma (Sweden) Analysis
| VICO Stock | SEK 8.69 0.46 5.03% |
Vicore Pharma Holding is overvalued with Real Value of 7.42 and Hype Value of 8.69. The main objective of Vicore Pharma stock analysis is to determine its intrinsic value, which is an estimate of what Vicore Pharma Holding is worth, separate from its market price. There are two main types of Vicore Pharma's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Vicore Pharma's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Vicore Pharma's stock to identify patterns and trends that may indicate its future price movements.
The Vicore Pharma stock is traded in Sweden on Stockholm Exchange, with the market opening at 09:00:00 and closing at 17:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Sweden. Vicore Pharma is usually not traded on All Saints ' Day, St . John 's Day, Christmas Eve, Christmas Day, Boxing Day, New Year 's Day, Epiphany, Good Friday, Easter Sunday, Easter Monday, International Workers ' Day, NationalDay. Vicore Stock trading window is adjusted to Europe/Stockholm timezone.
Vicore |
Vicore Stock Analysis Notes
About 16.0% of the company outstanding shares are owned by insiders. The company has Price/Earnings (P/E) ratio of 163.82. Vicore Pharma Holding recorded a loss per share of 4.76. The entity had not issued any dividends in recent years. The firm had 396:347 split on the 14th of September 2018. Vicore Pharma Holding AB , through its subsidiaries, operates as a biotech company. Vicore Pharma Holding AB was founded in 2000 and is based in Mlndal, Sweden. Vicore Pharma is traded on Stockholm Stock Exchange in Sweden. For more information please call the company at 46 3 17 88 05 60 or visit https://www.vicorepharma.com.Vicore Pharma Holding Investment Alerts
| Vicore Pharma had very high historical volatility over the last 90 days | |
| Vicore Pharma has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (296.48 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Vicore Pharma Holding has accumulated about 215.97 M in cash with (265.17 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.1. | |
| Roughly 16.0% of the company outstanding shares are owned by insiders |
Vicore Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.26 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Vicore Pharma's market, we take the total number of its shares issued and multiply it by Vicore Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 20th of January, Vicore Pharma has the Risk Adjusted Performance of 0.0219, semi deviation of 2.47, and Coefficient Of Variation of 5682.83. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Vicore Pharma Holding, as well as the relationship between them.Vicore Pharma Holding Price Movement Analysis
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Vicore Pharma middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Vicore Pharma Holding. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Vicore Pharma Outstanding Bonds
Vicore Pharma issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Vicore Pharma Holding uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Vicore bonds can be classified according to their maturity, which is the date when Vicore Pharma Holding has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
Vicore Pharma Predictive Daily Indicators
Vicore Pharma intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Vicore Pharma stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Vicore Pharma Forecast Models
Vicore Pharma's time-series forecasting models are one of many Vicore Pharma's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Vicore Pharma's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Vicore Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Vicore Pharma prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Vicore shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Vicore Pharma. By using and applying Vicore Stock analysis, traders can create a robust methodology for identifying Vicore entry and exit points for their positions.
Vicore Pharma Holding AB , through its subsidiaries, operates as a biotech company. Vicore Pharma Holding AB was founded in 2000 and is based in Mlndal, Sweden. Vicore Pharma is traded on Stockholm Stock Exchange in Sweden.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Vicore Pharma to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Instant Ratings Now
Instant RatingsDetermine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Additional Tools for Vicore Stock Analysis
When running Vicore Pharma's price analysis, check to measure Vicore Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vicore Pharma is operating at the current time. Most of Vicore Pharma's value examination focuses on studying past and present price action to predict the probability of Vicore Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vicore Pharma's price. Additionally, you may evaluate how the addition of Vicore Pharma to your portfolios can decrease your overall portfolio volatility.